ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment

Xia, Cong; Cai, Yantao; Ren, Shuangyi*; Xia, Chenglai*南方医科大学
Frontiers in Pharmacology2022-11-8DOI: 10.3389/fphar.2022.1051330
4被引7阅读
引用收藏
分享

摘要

The human gut microbiota is associated with the development and progression of colorectal cancer, and manipulation of the gut microbiota is a novel strategy for the prevention and treatment of colorectal cancer. Some bacteria have antitumor activity against colorectal cancer, where specific bacteria can improve the tumor microenvironment, activate immune cells including dendritic cells, helper T cells, natural killer cells, and cytotoxic T cells, and upregulate the secretion of pro-tumor immune cytokines such as interleukin-2 and interferon. In this paper, we summarize some bacteria with potential benefits in colorectal cancer and describe their roles in the tumor microenvironment, demonstrate the application of gut microbes in combination with immunosuppressive agents, and provide suggestions for further experimental studies and clinical practice applications.

学科与关键词

关键词
tumor microenvironmentimmunocytemicrobiomacytokincolorectal cancer
相关
加载中…
  • Gut microbiome in tumorigenesis and therapy of colorectal cancer
    Wang, Ling; Yu, Ke-Chun; Hou, Yun-qing; Guo, Min; Yao, Fan; Chen, Zhen-Xia*Journal of Cellular Physiology, 2023, 238(1): 94-108.被引 4
  • Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
    Ou, Suwen; Wang, Hufei; Tao, Yangbao; Luo, Kangjia; Ye, Jinhua; Ran, Songlin; Guan, Zilong; Wang, Yuliuming; Hu, Hanqing; Huang, Rui*Frontiers in Cellular and Infection Microbiology, 2022, 12: 1020583.被引 10
  • Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses
    Yu, Hao; Li, Xing-Xiu; Han, Xing; Chen, Bin-Xin; Zhang, Xing-Hua; Gao, Shan; Xu, Dan-Qi; Wang, Yao; Gao, Zhan-Kui; Yu, Lei; Zhu, Song-Ling; Yao, Li-Chen; Liu, Gui-Rong*; Liu, Shu-Lin*; Mu, Xiao-Qin*Frontiers in Microbiology, 2023, 14: 1126808.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-11-08
卷期
第 13 卷
页码
1051330
DOI
10.3389/fphar.2022.1051330
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Science and Technology Bureau of Foshan; [FS0AA-KJ218-1301-0008]; [FS0AA-KJ819-4,901-0082]

作者

  • X

    Xia, Cong (第一作者)

    2 · dalian med univ

  • C

    Cai, Yantao

    southern med univ

查看全部 4 位作者收起作者
  • R

    Ren, Shuangyi (通讯)

    2 · dalian med univ

  • X

    Xia, Chenglai (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417